Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach

For most cancers, chemotherapeutic options are rapidly expanding, providing the oncologist with substantial choices. Therefore, there is a growing need to select the best systemic therapy, for any individual, that effectively halts tumor progression with minimal toxicity. Having the capability to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattner, Jodi, Bathe, Oliver F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746740/
https://www.ncbi.nlm.nih.gov/pubmed/29144383
http://dx.doi.org/10.3390/metabo7040060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746740/
https://www.ncbi.nlm.nih.gov/pubmed/29144383
http://dx.doi.org/10.3390/metabo7040060

Ejemplares similares